Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Equivalence of BCSH and WHO diagnostic criteria for ET

Harrison, C
McMullin, M
Green, A
Mead, A

Publication date

January 2016

Publisher

Nature Publishing Group

Abstract

Correspondences on ‘Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria.’ By Gisslinger et al

Extracted data

Related items

Myeloproliferative neoplasms: Morphology and clinical practice

Barbui, Tiziano
Thiele, Juergen
Vannucchi, Alessandro M.
Tefferi, Ayalew

January 2016

In myeloproliferative neoplasms (MPNs), controversy persists regarding the usefulness and reproducib...

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.

Barosi G
Birgegard G
Finazzi G
Griesshammer M
Harrison C
Hasselbalch HC
Kiladjian JJ
Lengfelder E
McMullin MF
PASSAMONTI, FRANCESCO
Reilly JT
Vannucchi AM
Barbui T.

January 2009

European experts were convened to develop a definition of response to treatment in polycythemia vera...

Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia.

Carobbio A
Finazzi G
Thiele J
Kvasnicka HM
Passamonti F
Rumi E
Ruggeri M
Rodeghiero F
Luigia Randi M
Bertozzi I
Vannucchi AM
Antonioli E
Gisslinger H
Buxhofer-Ausch V
Gangat N
Rambaldi A
Tefferi A
Barbui T.

January 2012

According to World Health Organization (WHO)-defined criteria, patients presenting clinically as ess...

Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

Gisslinger, H.
Jeryczynski, G.
Gisslinger, B.
Wolfler, A.
Burgstaller, S.
Buxhofer-Ausch, V.
Schalling, M.
Krauth, M-T
Schiefer, A-I
Kornauth, C.
Simonitsch-Klupp, I.
Beham-Schmid, C.
Mullauer, L.
Thiele, J.

January 2016

Essential thrombocythemia (ET) is currently diagnosed either by the British Committee of Standards i...

WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.

Michiels, J.J.M.
Raeve, H. De
Hebeda, K.M.
Lam, K.H.
Berneman, Z.
Schroyens, W.
Schwarz, J.

January 2007

Contains fulltext : 53124.pdf (publisher's version ) (Closed access)The bone marro...

Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis

Brousseau, Maud
Parot-Schinkel, Elsa
Moles, Marie-Pierre
Boyer, Françoise
Hunault-Berger, Mathilde
Rousselet, Marie-Christine

January 2010

International audienceAims: To evaluate the feasibility of the histopathological diagnosis of prefib...

Value of bone marrow biopsy in the diagnosis of essential thrombocythemia

Florena, A.
Tripodo, C.
Iannitto, E.
Porcasi, R.
Ingrao, S.
Franco, V.

January 2004

Background and Objectives. Essential thrombocythemia (ET) is a Philadelphia chromosome-negative chro...

Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.

Barbui T
Thiele J
Passamonti F
Boveri E
Ruggeri M
Rodeghiero F
d'Amore ES
Randi ML
Bertozzi I
Marino F
Vannucchi AM
Antonioli E
Carrai V
Gisslinger H
Buxhofer Ausch V
Müllauer L
Carobbio A
Gianatti A
Gangat N
Hanson CA
Tefferi A.
RUMI, ELISA

January 2011

The WHO diagnostic criteria underscore the role of bone marrow (BM) morphology in distinguishing ess...

Differential diagnostic features of bone marrow biopsies in essential thrombocythemia

FRANCO, Vito
TRIPODO, Claudio
TEGOLO, Domenico
FLORENA, Ada Maria

January 2004

Essential Thrombocythemia (ET) is a chronic myeloproliferative disorder (CMPD) characterized by a h...

The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances

Barbui, T.
Thiele, J.
Gisslinger, H.
Finazzi, G.
Vannucchi, A. M.
Tefferi, A.

January 2016

Clinical evidence supports the need of changing the diagnostic criteria of the 2008 updated WHO clas...

The WHO diagnostic criteria for polycythemia vera-role of red cell mass versus hemoglobin/hematocrit level and morphology

Jakovic, Ljubomir
Gotic, Mirjana
Gisslinger, Heinz
Soldatovic, Ivan
Sefer, Dijana
Tirnanic, Mila
Lekovic, Danijela
Jovanovic, Maja Perunicic
Schalling, Martin
Gisslinger, Bettina
Beham-Schmid, Christine
Simonitsch-Klupp, Ingrid
Thiele, Juergen

January 2018

Regarding diagnosis of polycythemia vera (PV), discussion persists about hemoglobin (Hb) and/or hema...

Response The 2008 World Health Organization diagnostic criteria for polycythemia vera, essential

October 2016

thrombocythemia, and primary myelofibrosis: a paradigm of effective collaboration among clinicians, ...

Myeloproliferative neoplasms: Morphology and clinical practice

Barbui, Tiziano
Thiele, Juergen
Vannucchi, Alessandro M.
Tefferi, Ayalew

January 2016

In myeloproliferative neoplasms (MPNs), controversy persists regarding the usefulness and reproducib...

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.

Barosi G
Birgegard G
Finazzi G
Griesshammer M
Harrison C
Hasselbalch HC
Kiladjian JJ
Lengfelder E
McMullin MF
PASSAMONTI, FRANCESCO
Reilly JT
Vannucchi AM
Barbui T.

January 2009

European experts were convened to develop a definition of response to treatment in polycythemia vera...

Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia.

Carobbio A
Finazzi G
Thiele J
Kvasnicka HM
Passamonti F
Rumi E
Ruggeri M
Rodeghiero F
Luigia Randi M
Bertozzi I
Vannucchi AM
Antonioli E
Gisslinger H
Buxhofer-Ausch V
Gangat N
Rambaldi A
Tefferi A
Barbui T.

January 2012

According to World Health Organization (WHO)-defined criteria, patients presenting clinically as ess...

Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

Gisslinger, H.
Jeryczynski, G.
Gisslinger, B.
Wolfler, A.
Burgstaller, S.
Buxhofer-Ausch, V.
Schalling, M.
Krauth, M-T
Schiefer, A-I
Kornauth, C.
Simonitsch-Klupp, I.
Beham-Schmid, C.
Mullauer, L.
Thiele, J.

January 2016

Essential thrombocythemia (ET) is currently diagnosed either by the British Committee of Standards i...

WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.

Michiels, J.J.M.
Raeve, H. De
Hebeda, K.M.
Lam, K.H.
Berneman, Z.
Schroyens, W.
Schwarz, J.

January 2007

Contains fulltext : 53124.pdf (publisher's version ) (Closed access)The bone marro...

Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis

Brousseau, Maud
Parot-Schinkel, Elsa
Moles, Marie-Pierre
Boyer, Françoise
Hunault-Berger, Mathilde
Rousselet, Marie-Christine

January 2010

International audienceAims: To evaluate the feasibility of the histopathological diagnosis of prefib...

Value of bone marrow biopsy in the diagnosis of essential thrombocythemia

Florena, A.
Tripodo, C.
Iannitto, E.
Porcasi, R.
Ingrao, S.
Franco, V.

January 2004

Background and Objectives. Essential thrombocythemia (ET) is a Philadelphia chromosome-negative chro...

Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.

Barbui T
Thiele J
Passamonti F
Boveri E
Ruggeri M
Rodeghiero F
d'Amore ES
Randi ML
Bertozzi I
Marino F
Vannucchi AM
Antonioli E
Carrai V
Gisslinger H
Buxhofer Ausch V
Müllauer L
Carobbio A
Gianatti A
Gangat N
Hanson CA
Tefferi A.
RUMI, ELISA

January 2011

The WHO diagnostic criteria underscore the role of bone marrow (BM) morphology in distinguishing ess...

Differential diagnostic features of bone marrow biopsies in essential thrombocythemia

FRANCO, Vito
TRIPODO, Claudio
TEGOLO, Domenico
FLORENA, Ada Maria

January 2004

Essential Thrombocythemia (ET) is a chronic myeloproliferative disorder (CMPD) characterized by a h...

The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances

Barbui, T.
Thiele, J.
Gisslinger, H.
Finazzi, G.
Vannucchi, A. M.
Tefferi, A.

January 2016

Clinical evidence supports the need of changing the diagnostic criteria of the 2008 updated WHO clas...

The WHO diagnostic criteria for polycythemia vera-role of red cell mass versus hemoglobin/hematocrit level and morphology

Jakovic, Ljubomir
Gotic, Mirjana
Gisslinger, Heinz
Soldatovic, Ivan
Sefer, Dijana
Tirnanic, Mila
Lekovic, Danijela
Jovanovic, Maja Perunicic
Schalling, Martin
Gisslinger, Bettina
Beham-Schmid, Christine
Simonitsch-Klupp, Ingrid
Thiele, Juergen

January 2018

Regarding diagnosis of polycythemia vera (PV), discussion persists about hemoglobin (Hb) and/or hema...

Response The 2008 World Health Organization diagnostic criteria for polycythemia vera, essential

October 2016

thrombocythemia, and primary myelofibrosis: a paradigm of effective collaboration among clinicians, ...

Myeloproliferative neoplasms: Morphology and clinical practice

Barbui, Tiziano
Thiele, Juergen
Vannucchi, Alessandro M.
Tefferi, Ayalew

January 2016

In myeloproliferative neoplasms (MPNs), controversy persists regarding the usefulness and reproducib...

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.

Barosi G
Birgegard G
Finazzi G
Griesshammer M
Harrison C
Hasselbalch HC
Kiladjian JJ
Lengfelder E
McMullin MF
PASSAMONTI, FRANCESCO
Reilly JT
Vannucchi AM
Barbui T.

January 2009

European experts were convened to develop a definition of response to treatment in polycythemia vera...

Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia.

Carobbio A
Finazzi G
Thiele J
Kvasnicka HM
Passamonti F
Rumi E
Ruggeri M
Rodeghiero F
Luigia Randi M
Bertozzi I
Vannucchi AM
Antonioli E
Gisslinger H
Buxhofer-Ausch V
Gangat N
Rambaldi A
Tefferi A
Barbui T.

January 2012

According to World Health Organization (WHO)-defined criteria, patients presenting clinically as ess...